Author + information
- Felicitas Escher,
- Uwe Kuehl,
- Dirk Lassner,
- Wolfgang Poller,
- Carsten Tschoepe and
- Heinz-Peter Schultheiss
Intramyocardial inflammation is known to have an adverse prognostic impact in DCMi. However, the precise role of contributing pathogenic factors for a prediction the long-term course yet remains elusive. The aim of this study was to analyse the prognostic value of cytotoxic T-lymphocytes (CTLs: Perforin) in a large cohort of patients with dilated inflammatory cardiomyopathy (DCMi).
Methods and Results
We studied n=495 consecutive patients with virus negative DCMi, undergoing endomyocardial biopsies (EMBs). We examined haemodynamic measurements after a mean follow-up period of 3035 months. In EMBs myocardial inflammation was assessed by histology and immunohistology. At follow-up n=388 patients showed a stable normal or significant improvement of left ventricular ejection fraction (LVEF) from 46.2±14.8% to 64.3±12.3% (P<0.0001). No recovery of LVEF was observed in n=61 patients (development from 30.4±10.5% to 27.4±11.8%), and significant deterioration from mild to severe LV dysfunction was observed in n=46 patients (from 53.1±18.28% to 38.3±17.18%, P<0.0001). The latter was associated with a significant increase in perforin+ infiltrates in EMBs (6.3±3.9 perforin+ cells/mm2versus 0.8±1.0 perforin+ cells/mm2 in patients who recovered, P<0.0001). In a subgroup analysis of 104 patients with re-biopsy (mean 8.3±7.8 months), LV function decreased in patients with persistence of perforin+ infiltrates (LVEF from 54.3±16.1% to 39.2±16.1%) in 74.1% of these.
In this biopsy-based analysis of the long term course of DCMi, we showed an association between presence of perforin+ phenotypes detected in the myocardium of patients and prediction of failure for improvement of LV function in DCMi patients.
Poster Sessions, Expo North
Sunday, March 10, 2013, 3:45 p.m.-4:30 p.m.
Session Title: New Paradigms in Prognostic Role of Biomarkers in Heart Failure
Abstract Category: 15. Heart Failure: Clinical
Presentation Number: 1265-307
- 2013 American College of Cardiology Foundation